Sildenafil and its Maker and Big Pharma: A Dangerous Investment?

The outlook of companies tied to iconic drugs like Viagra presents a nuanced investment picture. While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial returns, the expiry in key markets has introduced considerable volatility. Investors are now assessing the effect of rival medications , reduced sale

read more